Senate Bars School Lunch Program from Purchasing Chickens Treated with Cipro-like Drugs

November 7, 2003

The United States Senate approved a measure that would prohibit the Department of Agriculture (USDA) from purchasing chickens for the school lunch program that have been treated with the cipro-like antibiotics known as fluoroquinolones. The amendment to the 2004 Agriculture appropriations bill, offered by Senator Hillary Rodham Clinton (D-NY), is the first time the Senate has addressed the overuse of medically important antibiotics in agriculture. The Agriculture bill passed last night.

Fluoroquinolones are doctors’ first choice in treating severe food poisoning in humans. The Food and Drug Administration has proposed to withdraw the use of fluoroquinolones in poultry because it contributes to increasing numbers of people becoming infected with bacteria that are resistant to antibiotics.

“Children are at a greater risk to suffer from food poisoning and infections from antibiotic resistant bacteria,” said Tamar Barlam, M.D., director of the antibiotic resistance project at the nonprofit Center for Science in the Public Interest (CSPI). “Even McDonald’s and Wendy’s have forced their suppliers to phase out fluoroquinolones. There’s no reason that school lunch program should lag behind the fast-food industry on this important public health issue.”

Several major chicken producers like Tyson, Gold Kist, and Perdue have committed to stop using fluoroquinolones in their chickens. Legislation offered by Representative Sherrod Brown (D-OH) would also prohibit USDA from buying fluoroquinolone-treated chicken for the school lunch program.


Get Updates Via Email

Journalists can receive CSPI news releases via email.
Not a journalist?

Sign Up for Email Now



Subscribe Now

Subscribe Now »

Subscribe Today and Save!

In Recent Issues

Cover Story: 1 in 8: What You May Not Know About Breast Cancer

Special Feature: Soy Oh Soy: Is It Really Bad For You?

Brand-Name Rating: Pasta Sauce

Subscribe Now

Request permission to reuse content

The use of information from this site for commercial purposes is strictly prohibited without written permission from CSPI.